Project Grant HT94252311034
Award Date
9/15/23
Completion Date
9/14/25
Dollars Obligated
$557K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90024, USA
Similar Awards
The University of California, Los Angeles (UCLA), through its Office of Research Administration, has been awarded a $2,351,564.00 Project Grant from the Defense Health Agency under the CFDA Program 12.420 - Military Medical Research and Development. This four-year grant, with a period of performance from August 15, 2023 to August 14, 2027, will support research targeting the EGFR signaling network in glioblastoma. As the prime grantee, UCLA will leverage its research facilities, faculty...
The Defense Health Agency has awarded a $893,000 Project Grant to the University of California, Los Angeles (UCLA) - Office of Research Administration to conduct research under the Military Medical Research and Development program (CFDA 12.420). This four-year grant, effective August 15, 2023 through August 14, 2027, will support UCLA's efforts to investigate the EGFR signaling network in glioblastoma, an aggressive form of brain cancer. As the prime grantee, UCLA will leverage its research...
The Department of the Army Medical Command awarded a $188,403 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the University of California, Los Angeles (UCLA) for the project "DEVELOPING NEW CELL-MEDIATED IMMUNOTHERAPEUTIC STRATEGIES FOR SMALL-CELL LUNG CANCER". The award, which runs from January 1, 2025 to December 31, 2025, supports advanced biomedical research focused on transforming healthcare for military service members and the broader...
The University of California, Los Angeles (UCLA), under its Office of Research Administration, received a $157,473 Project Grant award from the Defense Health Agency (DHA) on May 1, 2024 to conduct research for the "TESTING UCHL1 AS A NEW MINIMALLY INVASIVE BIOMARKER AND THERAPEUTIC TARGET FOR NEUROENDOCRINE PROSTATE CANCER" project. This award is funded through the DHA's Military Medical Research and Development program (CFDA 12.420), which supports a range of biomedical research...
The Defense Health Agency awarded the University of California, Los Angeles (UCLA) a $250,000 Project Grant titled "Probing Oligodendrocyte Lineage Cell Autocrine Signals to Treat Multiple Sclerosis" under the Military Medical Research and Development program (CFDA 12.420). This two-year grant, with a performance period from August 15, 2023 to August 14, 2025, supports UCLA's research to investigate treatment approaches for multiple sclerosis by studying autocrine signaling in...
The University of California, Los Angeles (UCLA) has been awarded a $626,081 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program, administered by the Defense Health Agency. The grant, titled "Combinatorial Phenotype-Targeted Therapy to Overcome Mechanisms Driving Prostate Cancer Treatment Resistance," will support advanced biomedical research to transform healthcare for military service members and the broader public. The research...
The University of California, Los Angeles (UCLA), through its Office of Research Administration, has been awarded a $2,519,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 1, 2024, will support research to investigate the role of inducible trypsins in mediating misfolding-dependent chronic pancreatitis, with a project completion date of March 31, 2028. As a prime grantee,...
The University of California, Los Angeles (UCLA) was awarded a $472,500 Project Grant under the Military Medical Research and Development (CFDA 12.420) program, administered by the Defense Health Agency. The grant, titled "Targeting TROP2-Mediated Ferroptosis as a New Therapy for Advanced Prostate Cancer," aims to advance biomedical research focused on transforming healthcare for military service members and the general public. The award, effective May 1, 2025, with a completion date...
The University of California, Los Angeles (UCLA), through its Office of Research Administration, was awarded a $1,366,628 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into the role of oxidative mitochondrial metabolism in resistance to androgen receptor inhibition from July 1, 2023 to June 30, 2026. As the prime awardee, UCLA will leverage its research facilities and faculty...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $757,941 Project Grant to The General Hospital Corporation (Massachusetts General Hospital) on July 1, 2024. The grant supports a 3-year randomized clinical trial to evaluate a mobile application aimed at improving health outcomes for patients with advanced lung cancer. As part of the project, The General Hospital Corporation has issued a $245,669 sub-award to the University of California, Los...